In September 1995, the FDA in the beginning authorized testosterone transdermal patches (Androderm); numerous transdermal types and brands are actually obtainable which includes implants, gels, and topical alternatives. A testosterone buccal system, Striant, was FDA approved in July 2003; the procedure is really a mucoadhesive product that adheres